Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.04.29
2018年度财务决算报告
2019.04.29
关于公司召募资金年度存放与现实使用情形的鉴证报告
2019.04.29
关于深圳市多普乐实业生长有限公司2018年度业绩允许完成情形的说明
2019.04.29
上市公司内部控制规则落实自查表
2019.04.24
关于2019年非果真刊行公司债券刊行效果的通告
2019.04.19
关于控股子公司新药临床试验申请获得受理的通告
2019.04.08
关于注销部分召募资金专户的通告
2019.03.30
2019年度第一季度业绩预告
2019.03.19
2019年第一次暂时股东大会的执法意见书
2019.03.19
2019年第一次暂时股东大会决议通告
第一页
上一页
48
49
50
51
52
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】